Tarawneh et al. examined the diagnostic efficacy of neurogranin levels in a cross-sectional and longitudinal observational study of 207 cognitively normal controls and 95 individuals with early symptomatic Alzheimer’s disease [262]. This evidence concerns the gene NRGN and early-onset autosomal dominant Alzheimer disease.